J.P. Morgan Healthcare Conference
NanoString announced preliminary financial/operational highlights for both the fourth quarter and all of 2022 going into this event; listen to the audio stream for the complete announcement. Highlights include:
- Record Orders for Over 105 Spatial Biology Instruments in Q4, Representing 50% Growth Year-over-Year
- Q4 Product and Service Revenue of Over $34 Million
Further specifics are also available in our press release.